Tata India Pharma & Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 17-01-2025
NAV ₹30.06(R) +0.39% ₹34.7(D) +0.39%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 30.32% 19.35% 25.7% 18.66% -%
LumpSum (D) 32.25% 21.13% 27.6% 20.52% -%
SIP (R) 20.59% 29.4% 23.79% 22.9% -%
SIP (D) 22.38% 31.29% 25.6% 24.72% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.87 0.5 0.86 3.19% 0.14
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.17% -14.79% -14.4% 0.92 10.08%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -
Dsp Healthcare Fund -

NAV Date: 17-01-2025

Scheme Name NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 30.06
0.1200
0.3900%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 30.06
0.1200
0.3900%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 30.06
0.1200
0.3900%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 34.7
0.1400
0.3900%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 34.7
0.1400
0.3900%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 34.7
0.1400
0.3900%

Review Date: 17-01-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It denotes the rise in the investment's worth during the investment period, expressed as a percentage or a monetary value. As part of our analysis, we evaluated six return parameters of this fund. We have classified the return parameters into three performance groups: the top 25%, parameters that fall below the top 25% but remain above average, and parameters that are below average. The performance of each parameter is outlined below.
    1. Top 25%: One return parameter of the Tata India Pharma & Healthcare Fund is in the top 25% in the category, as shown below:
      • 1M Return %
    2. Above Average Below the Top 25%: Two return parameters of the Tata India Pharma & Healthcare Fund are above average but below the top 25% in the category, as shown below:
      • 3M Return %
      • 3Y Return %
    3. Below Average: Tata India Pharma & Healthcare Fund has three return parameters that are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 6M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Tata India Pharma & Healthcare Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: one risk parameter in the lowest 25% in the category, which is listed below.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.08 %.
    2. Below Average but Above the Lowest 25%: Tata India Pharma & Healthcare Fund has one risk parameter that is below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.17 %.
    3. Above Average: Tata India Pharma & Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has three risk-adjusted performance parameters of the fund that are in the this group of the category.
      • Sharpe Ratio: Tata India Pharma & Healthcare Fund has a Sharpe Ratio of 0.87 compared to the category average of 0.84.
      • Sterling Ratio: Tata India Pharma & Healthcare Fund has a Sterling Ratio of 0.86 compared to the category average of 0.78.
      • Sortino Ratio: Tata India Pharma & Healthcare Fund has a Sortino Ratio of 0.5 compared to the category average of 0.46.
    3. Below Average Risk Adjusted Performance Parameters: Tata India Pharma & Healthcare Fund has one risk-adjusted performance parameter of the fund that is below average in the category.
      • Treynor Ratio: Tata India Pharma & Healthcare Fund has a Treynor Ratio of 0.14 compared to the category average of 0.14.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.25
-1.85
-3.07 | -0.21 4 | 13 Very Good
3M Return % -3.06
-3.32
-11.16 | -0.52 8 | 13 Good
6M Return % 9.29
10.35
-2.06 | 16.97 9 | 13 Average
1Y Return % 30.32
30.34
18.33 | 39.68 7 | 12 Average
3Y Return % 19.35
19.24
16.25 | 22.78 4 | 8 Good
5Y Return % 25.70
26.40
22.23 | 28.77 7 | 8 Poor
7Y Return % 18.66
18.27
17.31 | 19.34 2 | 4 Good
1Y SIP Return % 20.59
18.39
-7.32 | 33.71 6 | 12 Good
3Y SIP Return % 29.40
29.67
26.66 | 34.85 5 | 8 Average
5Y SIP Return % 23.79
24.09
21.00 | 27.27 5 | 8 Average
7Y SIP Return % 22.90
23.06
22.57 | 24.05 2 | 4 Good
Standard Deviation 15.17
15.28
14.18 | 16.03 4 | 8 Good
Semi Deviation 10.08
10.39
10.01 | 10.81 2 | 8 Very Good
Max Drawdown % -14.40
-16.33
-18.46 | -14.07 2 | 8 Very Good
VaR 1 Y % -14.79
-16.75
-18.96 | -14.68 2 | 8 Very Good
Average Drawdown % -4.20
-5.31
-6.71 | -4.20 1 | 8 Very Good
Sharpe Ratio 0.87
0.84
0.64 | 1.10 3 | 8 Good
Sterling Ratio 0.86
0.78
0.66 | 1.01 3 | 8 Good
Sortino Ratio 0.50
0.46
0.36 | 0.64 3 | 8 Good
Jensen Alpha % 3.19
2.90
-0.76 | 7.18 4 | 8 Good
Treynor Ratio 0.14
0.14
0.11 | 0.19 4 | 8 Good
Modigliani Square Measure % 22.27
21.99
18.25 | 26.72 3 | 8 Good
Alpha % 1.77
1.16
-1.64 | 5.07 3 | 8 Good
Return data last Updated On : Jan. 17, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.13 -1.74 -2.97 | -0.15 4 | 13
3M Return % -2.70 -3.00 -10.79 | -0.22 7 | 13
6M Return % 10.08 11.07 -1.24 | 17.91 9 | 13
1Y Return % 32.25 32.01 20.29 | 41.43 7 | 12
3Y Return % 21.13 20.68 18.00 | 23.87 4 | 8
5Y Return % 27.60 27.98 24.12 | 30.53 5 | 8
7Y Return % 20.52 19.62 18.51 | 20.52 1 | 4
1Y SIP Return % 22.38 19.93 -5.98 | 35.41 6 | 12
3Y SIP Return % 31.29 31.21 28.40 | 36.01 4 | 8
5Y SIP Return % 25.60 25.58 22.74 | 28.39 4 | 8
7Y SIP Return % 24.72 24.41 23.65 | 25.35 2 | 4
Standard Deviation 15.17 15.28 14.18 | 16.03 4 | 8
Semi Deviation 10.08 10.39 10.01 | 10.81 2 | 8
Max Drawdown % -14.40 -16.33 -18.46 | -14.07 2 | 8
VaR 1 Y % -14.79 -16.75 -18.96 | -14.68 2 | 8
Average Drawdown % -4.20 -5.31 -6.71 | -4.20 1 | 8
Sharpe Ratio 0.87 0.84 0.64 | 1.10 3 | 8
Sterling Ratio 0.86 0.78 0.66 | 1.01 3 | 8
Sortino Ratio 0.50 0.46 0.36 | 0.64 3 | 8
Jensen Alpha % 3.19 2.90 -0.76 | 7.18 4 | 8
Treynor Ratio 0.14 0.14 0.11 | 0.19 4 | 8
Modigliani Square Measure % 22.27 21.99 18.25 | 26.72 3 | 8
Alpha % 1.77 1.16 -1.64 | 5.07 3 | 8
Return data last Updated On : Jan. 17, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.39 ₹ 10,039.00 0.39 ₹ 10,039.00
1W -1.70 ₹ 9,830.00 -1.68 ₹ 9,832.00
1M -1.25 ₹ 9,875.00 -1.13 ₹ 9,887.00
3M -3.06 ₹ 9,694.00 -2.70 ₹ 9,730.00
6M 9.29 ₹ 10,929.00 10.08 ₹ 11,008.00
1Y 30.32 ₹ 13,032.00 32.25 ₹ 13,225.00
3Y 19.35 ₹ 17,000.00 21.13 ₹ 17,771.00
5Y 25.70 ₹ 31,380.00 27.60 ₹ 33,822.00
7Y 18.66 ₹ 33,133.00 20.52 ₹ 36,934.00
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 20.59 ₹ 13,301.47 22.38 ₹ 13,411.45
3Y ₹ 36000 29.40 ₹ 54,950.98 31.29 ₹ 56,351.88
5Y ₹ 60000 23.79 ₹ 108,250.44 25.60 ₹ 113,062.14
7Y ₹ 84000 22.90 ₹ 190,085.95 24.72 ₹ 202,749.88
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Tata India Pharma & Healthcare Fund NAV Regular Growth Tata India Pharma & Healthcare Fund NAV Direct Growth
17-01-2025 30.0647 34.6967
16-01-2025 29.9489 34.5616
15-01-2025 29.907 34.5119
14-01-2025 30.2034 34.8526
13-01-2025 29.8715 34.4682
10-01-2025 30.5858 35.2883
09-01-2025 31.211 36.0082
08-01-2025 31.4411 36.2722
07-01-2025 31.7253 36.5986
06-01-2025 31.4764 36.31
03-01-2025 31.8043 36.684
02-01-2025 32.0131 36.9233
01-01-2025 31.8795 36.7678
31-12-2024 31.7721 36.6424
30-12-2024 31.564 36.401
27-12-2024 31.3224 36.1182
26-12-2024 30.9415 35.6774
24-12-2024 30.8763 35.5995
23-12-2024 30.7962 35.5057
20-12-2024 30.8171 35.5256
19-12-2024 31.0685 35.814
18-12-2024 30.6942 35.3811
17-12-2024 30.4443 35.0917

Fund Launch Date: 04/Dec/2015
Fund Category: Pharma Fund
Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.